Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.27
0.00 (0.00%)
At close: Dec 27, 2024
Bicara Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bicara Therapeutics stock have an average target of 41.33, with a low estimate of 35 and a high estimate of 47. The average target predicts an increase of 126.22% from the current stock price of 18.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BCAX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|
Strong Buy | 2 | 2 | 3 |
Buy | 2 | 2 | 2 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +129.89% | Dec 6, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 8, 2024 |
Stifel | Stifel | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +157.25% | Oct 8, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +91.57% | Oct 8, 2024 |
TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.65
from -89.61
EPS Next Year
-1.78
from -2.65
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.45 | -1.49 | -1.95 |
Avg | -2.65 | -1.78 | -2.34 |
Low | -3.77 | -2.45 | -2.70 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.